Cellular reprogramming for pancreatic β-cell regeneration: clinical potential of small molecule control.
about
Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem CellsReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementCellular reprogramming for understanding and treating human disease.Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives.Treatment with specific soluble factors promotes the functional maturation of transcription factor-mediated, pancreatic transdifferentiated cells.
P2860
Cellular reprogramming for pancreatic β-cell regeneration: clinical potential of small molecule control.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cellular reprogramming for pan ...... ial of small molecule control.
@en
type
label
Cellular reprogramming for pan ...... ial of small molecule control.
@en
prefLabel
Cellular reprogramming for pan ...... ial of small molecule control.
@en
P2860
P356
P1476
Cellular reprogramming for pan ...... ial of small molecule control.
@en
P2093
Hiroshi Sugiyama
Junichi Taniguchi
P2860
P2888
P356
10.1186/2001-1326-3-6
P577
2014-03-27T00:00:00Z
P5875
P6179
1013374575